Consistent with the capacity of HGS stroke serum to induce endothelial dysfunction 1 year after stroke onset, IL-1β levels were significantly elevated at this long-term stage, confirming that the effect of serum is likely associated with atherosclerosis rather than stroke. The gene discussed is IL1B; the disease is endothelial dysfunction.